Positive FDA Meeting Outlines Path Ahead for Akari Therapeutics's Coversin in Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)

Stock Information for Akari Therapeutics Plc

Loading

Please wait while we load your information from QuoteMedia.